Home / Drug shortages / Aprepitant Oral Powder for Suspension

Aprepitant Oral Powder for Suspension — FDA Drug Shortage

To Be Discontinued — Merck Sharp & Dohme LLC

The FDA lists a drug shortage record for Aprepitant Oral Powder for Suspension from Merck Sharp & Dohme LLC with status To Be Discontinued. The shortage was first posted on 04/08/2026.

Shortage Details

Status
To Be Discontinued
Company
Merck Sharp & Dohme LLC
Package NDC
0006-3066-03
Dosage Form
Presentation
Emend, Oral Powder for Suspension, 125 mg (NDC 0006-3066-03)
Initial Posting
04/08/2026
Revised Date

FDA data resources